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Abstract
Background: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. It
is also well established that HPV viruses are responsible for a variety of cancers. Little is known about the prevailing
knowledge and attitudes toward the HPV vaccine in our future healthcare providers, a majority of whom were among
the first in the target age group to receive the vaccine; the same vaccine that they will in turn be expected to
recommend to their patients. The aims of this pilot study were to examine the HPV vaccination rate among medical
students and determine their knowledge about HPV and attitudes toward vaccination.
Methods: To aid in the development of an HPV educational intervention, a needs assessment survey was administered
to discover medical students’ knowledge and attitudes toward the HPV vaccine. All medical students at a Midwestern
US medical school were invited to complete the survey.
Results: Two hundred fourteen of 390 medical students completed the survey with 44% having been previously
vaccinated. Although 82% of all respondents believed they would recommend the vaccine to family and friends, only
40% felt knowledgeable about the vaccine and 40% felt comfortable counseling patients. More positive attitudes and
better knowledge scores were found in fully vaccinated students compared to non-vaccinated students. Provider
recommendation was strongly associated with HPV vaccination status.
Conclusions: This study revealed the unique perspectives of U.S. millennial medical students as the first group of
future healthcare providers to have personally encountered the HPV vaccine. Overall, students’ knowledge as well as
their comfort level in counseling patients was lacking. This assessment has guided the development of targeted
educational interventions to address knowledge gaps and prepare students to appropriately discuss the vaccine with
patients and parents and help protect young people from life threatening cancers.
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Background
Human papillomavirus (HPV) is the most common sexu-
ally transmitted infection in the United States [1]. The link
between HPV viruses and malignancies in both men and
women is well established with HPV genotypes 16 and 18
being responsible for nearly all cervical cancers [2]. HPV
is also responsible for 91% of anal cancers, 75% of vaginal
cancers, 63% of penile cancers, 69% of vulvar cancers and
60% of oropharyngeal cancers in the US [2, 3]. Three HPV
vaccines are currently licensed in the United States for the
prevention of infection due to HPV infection: Gardasil
and Cervarix that offer protection against oncogenic geno-
types 16 and 18 and the new Gardasil 9, which has the po-
tential to prevent approximately 90% of cervical, vulvar,
vaginal, and anal cancers caused by HPV types 16, 18, 31,
33, 45, 52, and 58 [4].
The United States Advisory Committee on Immu-
nization Practices recommends vaccination for all girls
and boys starting at 11 or 12 years of age, with catch up
vaccination between ages 13–26 in women and 13–21 in
men [5]. Even though it has been a decade since the HPV
vaccine was approved in June 2006, there is still a lack of
widespread uptake of this cancer-preventing vaccine. In
2014, only 40% of adolescent girls (age 13–17) and 22% of
adolescent boys in the US received all 3 doses of the
vaccine [6]. Due to the under-utilization of the HPV vac-
cination, 69 National Cancer Institute-designated Cancer
Centers jointly issued a call to action to increase HPV
vaccination rates in early 2016 [7].
Although well studied internationally [8, 9], very little is
known about US medical students’ knowledge and attitudes
about the HPV vaccine. This is especially important as US
millennial medical students will be the first generation of
providers who may have received the vaccine beginning in
2006; the same vaccine that they will now be expected to
recommend to their patients. A 2016 study surveyed high
school to health care professional students (including med-
ical students) in New York State [10]. The authors partly
conclude that this is related to health care professional stu-
dents being less likely to have been recommended the
vaccine by a health care provider than their younger coun-
terparts - high school and college students [10]. Students
who reported that their HPV vaccine information source
was the doctor had a higher vaccine completion rate when
compared to students whose information source was family
and friends. However, one major limitation of this study
was that data was not separated by type of health profes-
sion student, so prevailing attitudes of US medical students
remains unclear. In their educational intervention for physi-
cians, medical students, and non-physicians, Berenson et al.
[11] found medical students had inadequate baseline know-
ledge of HPV epidemiology and the HPV vaccine, but after
attending a brief, 30 minutes lecture increased their know-
ledge scores significantly. This demonstrates the potential
for using educational interventions to increase HPV vaccine
knowledge in this population.
Objectives
The primary aims of this pilot study were to examine
HPV vaccination rates among medical students and sur-
vey their knowledge and attitudes toward vaccination.
Additionally, comparisons were sought between vacci-
nated versus non-vaccinated students. A secondary aim
was to evaluate students’ perceived levels of comfort in
counseling patients about HPV vaccine. This data will be
used to develop and tailor educational interventions on
the HPV vaccine at our medical school.
Methods
Participants
Participants included all 390 medical students enrolled
at a single US Midwest allopathic medical school in
October 2015. Participation in the study was voluntary
with no compensation provided.
Measurements
Participants were invited via email to complete an an-
onymous online survey on HPV. No signed consent was
required since the survey was distributed via an online
platform. An information sheet was emailed to the student
to let them know about the study and that their computer
IP address would not be collected. Participants could ac-
cess the survey at a time and location of their choosing to
optimize privacy while completing the survey. Completion
of the survey indicated consent. The University’s Institu-
tional Review Board approved the study protocol.
The email contained a link to an anonymous, 20-
question online survey and an information sheet about
the study. Two email reminders were sent 1 week apart.
The survey included a mix of 5-point Likert scale, categor-
ical (yes/no), and free text completion items. Items in-
cluded: 1) demographic information; 2) vaccination status
for HPV; 3) motivating factors for accepting or rejecting
the vaccine; and 4) basic knowledge about HPV and the
HPV vaccine. Attitude questions about HPV vaccination
included: beliefs about the safety and efficacy of the vac-
cine, views on mandatory vaccination, comfort in provid-
ing counseling about vaccination, and intention to
recommend vaccination to friends and family. Participants
were also invited to comment on their views about the
vaccine. Previous research on HPV and influenza vaccin-
ation uptake assisted in formulating the content of this
pilot questionnaire [12–14].
Qualitative analysis
Analysis of answers to the open-ended questions followed
the grounded theory methodology [15]. A sub-group of in-
vestigators (JMS, TW and NMA) independently developed
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initial coding themes and then met to discuss and agree on
a common coding approach and code definitions. Discrep-
ancies were discussed and resolved. Responses were
grouped under the key themes identified.
Statistical analysis
Likert scale items were coded such that higher values cor-
responded to stronger agreement (1 = strongly disagree
and 5 = strongly agree). Additionally, Likert scale items
were collapsed to reflect overall agreement (by combining
scores of 4 (agree) and 5 (strongly agree)). Categorical var-
iables are reported as counts and percentage frequencies.
They were examined using Fisher’s Exact test.
Sub-analyses were conducted based on gender and vac-
cination status. Students who had completed all 3 doses of
the vaccine were considered fully vaccinated. Students
who did not receive any doses of the vaccine were consid-
ered non-vaccinated. Partially vaccinated students (com-
pleted 1 or 2 doses of the vaccine) were excluded from the
sub-analyses, as we did not have background information
on the reasons for not completing all doses of the vaccine,
which may introduce bias into the attitudes regarding the
vaccine. All analyses used The SAS® System for Windows
version 9.3, Cary, NC.
Results
Study sample
The overall response rate for the survey was 54.9% (214/
390 students). Response rates varied by class, with 55.5%
(71/128) of first year medical students, 62.5% (60/96) of
second year medical students, 45.9% (45/98) of third
year medical students, and 55.9% (38/68) of fourth year
medical students responding to the survey. Demographic
characteristics of respondents may be found in Table 1.
Knowledge of HPV vaccine
Although a majority of the 214 participants appeared well
informed about HPV and vaccine safety (Table 2), there
were evident gaps in knowledge about the protective effect
of the HPV vaccine in cancers other than cervical, and im-
munity provided by the vaccine. Twenty-one percent of
the participants (n = 44) did not know that the vaccine
was recommended for girls and boys. Overall, fully vacci-
nated participants scored better in knowledge items than
non-vaccinated participants (Table 3). Female participants
were generally more knowledgeable than males, specific-
ally with regards to the vaccine being recommended for
both girls and boys (p = 0.002) (Table 2).
Attitudes toward HPV vaccine
While most participants believed they would recom-
mend the vaccine to family and friend, less than half
perceived themselves as having adequate information
to counsel patients, or felt comfortable in their ability
to counsel patients. Only a small percent (7%) per-
ceived that the vaccine would lead to risky sexual be-
havior (Table 2). There were statistically significant
differences (p < 0.05) in scores between vaccinated
and non-vaccinated participants on perception of vac-
cine safety and efficacy (Table 3). Overall, over half of
responding participants (53.8%, n = 112) felt that the
vaccine should be mandatory (Table 2). However, a
marked difference was seen in the view on mandatory
vaccination between the fully vaccinated and non–
vaccinated students (see Table 3), with 72.6% (n = 53)
of fully vaccinated students agreeing that the vaccine
should be mandatory as compared to 38.3% (n = 44)
of non-vaccinated students (p < 0.001).
Of the 214 participants, 113 commented on “What are
your views on HPV vaccination?” revealing five major
themes: benefits of vaccination, emphasis on offering
vaccine to boys and girls, moral implications associated
with the HPV vaccine, need for counseling skills, and
need for education. Frequency distribution of each
theme and sample quotations that best represent each
theme are provided in Table 4.
Table 1 Participant characteristics (N = 214)
Characteristics n (%)
Age
≤25 years 141 (66.2)
26–30 years 64 (30.0)




Year in medical school
1st year 71 (33.2)
2nd year 60 (28.0)
3rd year 45 (21.0)
4th year 38 (17.8)
Race/Ethnicity
Asian 53 (25.0)





Fully vaccinated (3 doses) 75 (35.2)
Partially vaccinated (2 doses) 11 (5.2)
Partially vaccinated (1 dose) 8 (3.8)
Non-vaccinated 119 (55.9)
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Vaccination status
Fully vaccinated (n = 75) and partially vaccinated (n = 19)
students accounted for 44.1% (n = 94/213) of the sample.
The 25 years and below age group had the highest number
of participants who had received at least one dose of vac-
cine (50.7%, n = 71/140), when compared to both the 26–
30 years age group (32.8%, n = 21/64) and 31 years and
above age group (25.0%, n = 2/8). In this youngest age
group, 59.0% (n = 49/83) of women received the complete
series of the vaccine as compared to 8.8% (n = 5/57) of
men; 72.3% (n = 60) of women and 19.3% (n = 11) of men
in this group received at least one dose.
The principal reasons for vaccination cited by partici-
pants who had received at least one dose of the HPV
vaccine were provider recommendation (71.3%, n = 67)
and desire for self-protection (67.0%, n = 63). Among
the non-vaccinated group, the main reasons identified
were lack of provider recommendation (48.7%, n = 58),
a perception that they were not at risk for HPV (22.7%,
n = 27), and lack of information about the vaccine
(18.5%, n = 22). Parental desire for vaccination played a
role for 48.9% (n = 46) respondents receiving at least
one dose of the vaccine, whereas parental reluctance
was a 8.4% (n=10) of non-vaccinated respondents. Add-
itionally, 21.8% (n = 26) of non-vaccinated participants
believed they were not in the right age group to be
vaccinated. The fully vaccinated participants also felt
they would recommend the vaccine to friends and fam-
ily compared to non-vaccinated participants (p ≤ 0.01)
(Table 3).
Discussion
The HPV vaccine was introduced in 2006 for girls and
added to the list of approved vaccines for boys in 2011.
Although several studies have examined vaccination
practices and attitudes toward HPV vaccination in
practicing physicians [14, 16–18] and in international
medical students and residents [8, 9, 11–13, 19], the au-
thors only found one study reporting HPV vaccination
rates in US medical students [10]. However, in that
study all health care professional students were lumped
into a single student category so there was no way to
separate out medical student data [10]. Assessing med-
ical student knowledge and attitudes about the HPV
vaccine is vital since many in this group were likely to
be the initial recipients of the HPV vaccine that was
first offered in 2006. When these students become phy-
sicians they will carry with them this unique personal
experience not found in other older health care pro-
viders. The current study represents the first report of
HPV vaccination rates, knowledge, and attitudes among
these US medical students.

















HPV is a sexually transmitted infection 199 (93.4) 92 (92.0) 106 (94.6) 0.58
Men and women can be carriers of HPV 202 (94.8) 92 (91.1) 109 (98.2) 0.03*
HPV vaccine protects against genital warts 159 (74.3) 76 (75.2) 82 (73.2) 0.76
HPV vaccine protects against cervical cancer 195 (91.1) 91 (90.1) 103 (92.0) 0.64
HPV vaccine protects against other cancers 105 (49.5) 50 (50.0) 54 (48.6) 0.89
HPV vaccine is safe 191 (90.1) 87 (87.0) 103 (92.8) 0.17
HPV vaccine is effective 194 (91.1) 91 (90.1) 102 (91.9) 0.81
HPV vaccine has few side effects 163 (76.9) 69 (69.7) 93 (83.0) 0.03*
HPV vaccination leads to lasting immunity 120 (56.3) 56 (55.4) 63 (56.8) 0.89
HPV vaccine is recommended for girls and boys 169 (79.3) 70 (70.0) 98 (87.5) 0.002*
Attitude Items
HPV vaccination may lead to risky sexual behavior 15 (7.0) 12 (11.9) 3 (2.7) 0.01*
I have enough information to be able to counsel about
HPV vaccine
86 (40.3) 37 (37.0) 48 (42.9) 0.40
I feel comfortable counseling about HPV vaccination 86 (40.3) 40 (40.0) 45 (40.2) 1.00
I would recommend the HPV vaccine to friends and family 173 (81.6) 74 (74.8) 98 (87.5) 0.02*
HPV vaccine should be mandatory 112 (53.8) 47 (47.5) 65 (60.2) 0.07
aPositive response: Agree and Strongly Agree Likert scale responses were collapsed
*p < 0.05
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In the under 25 age group, we found HPV vaccin-
ation rates for female and male medical students who
had received at least one dose to be 72.3% and 19.3%
respectively, a markedly higher coverage rate than the
most recently reported national figures of 40.2% for
females and 8.2% for males in a similar age group in
2014 [20]. Similar to other college students, the higher
overall vaccination rates among medical students may
be the result of better knowledge, motivation, and bet-
ter access to vaccinations and healthcare [21–23]. The
majority of the students who were vaccinated ap-
peared to have a better understanding of HPV patho-
genesis and the safety and efficacy of the HPV
vaccine. It is additionally interesting to note that 73%
of vaccinated students felt that vaccination should be
mandatory as compared to 38% of non-vaccinated stu-
dents. Although the authors are aware of no data on
HPV vaccine receipt by health care providers, we be-
lieve that positive attitudinal differences in medical
students who are HPV vaccine recipients, are similar
to other vaccine studies, which show previous vaccin-
ation tends to impart a positive influence [13, 24].
Similar to our previous work on influenza vaccine, the
current study showed a significantly higher likelihood
of previously vaccinated students recommending influ-
enza vaccination to friends and family [13].
The current study strongly supports the assertion that
provider recommendation is a consistent and powerful
predictor of vaccination, as evidenced by the large pro-
portion of vaccinated students citing provider recom-
mendation as a reason they received it. Gilkey et al. [16]
found that participants who received a provider recom-
mendation were 35 times more likely to receive HPV
vaccination [25]. Gilkey et al. [16] also found that vac-
cine uptake was adversely affected if health providers in-
troduced the topic of HPV vaccination without expressly
recommending it. Again, when comparing health profes-
sions students to high school and college level, Suryade-
vara et al. [10] found that most health professions
students had not been counseled about the HPV vaccine
and attributed this to lower uptake of the vaccine by this
population.
Our survey also revealed deficits in student knowledge
and misperceptions about HPV. Although a majority of
the students were well informed about HPV transmis-
sion (93.4%), cervical cancer (91.1%), and vaccine safety
(90.1%), there was lack of knowledge about the protect-
ive effect of the HPV vaccine in cancers other than cer-
vical (49.5%) as well as the duration of immunity
provided by the vaccine. (56.3%) There was also the per-
ception among the non-vaccinated students that they
were not at risk for HPV. Greater emphasis, therefore,













HPV is a sexually transmitted infection 73 (97.3) 106 (89.8) 0.08
Men and women can be carriers of HPV 74 (98.7) 108 (91.5) 0.05
HPV vaccine protects against genital warts 58 (77.3) 86 (72.3) 0.50
HPV vaccine protects against cervical cancer 72 (96.0) 104 (87.4) 0.07
HPV vaccine protects against other cancers 36 (48.0) 56 (47.9) 1.00
HPV vaccine is safe 71 (95.9) 102 (85.7) 0.03*
HPV vaccine is effective 71 (95.9) 104 (87.4) 0.07
HPV vaccine has few side effects 64 (85.3) 83 (70.3) 0.02*
HPV vaccination leads to lasting immunity 49 (65.3) 58 (49.2) 0.04*
HPV vaccine is recommended for girls and boys 68 (90.7) 83 (70.3) <0.001*
Attitude items
HPV vaccination may lead to risky sexual behavior 4 (5.3) 10 (8.4) 0.57
I have enough information to be able to counsel about HPV
vaccine
35 (46.7) 45 (38.1) 0.29
I feel comfortable counseling about HPV vaccination 34 (45.3) 44 (37.3) 0.29
I would recommend the HPV vaccine to friends and family 73 (97.3) 81 (69.2) <0.001*
HPV vaccine should be mandatory 53 (72.6) 44 (38.3) <0.001*
aPositive responses: Agree and Strongly Agree Likert scale responses were collapsed
*p < 0.05
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needs to be placed in teaching about the importance of
HPV in disease etiology and the causal role of HPV in a
variety of cancers [2, 3]. Initiatives geared toward edu-
cating medical students about HPV vaccine should focus
on cancer prevention and include data on safety and effi-
cacy and strategies for positively framing counseling
messages to patients.
Our previous experience illustrates the effectiveness of
an early intervention coupled with experiential learning
when teaching about influenza vaccination [13]. Guided
by this assessment, beginning this academic year, we
have developed and integrated multi-faceted educational
interventions aimed at improving knowledge of HPV,
cancer and vaccines, as well as providing students hands
on experience practicing vaccine counseling with stan-
dardized patients. We anticipate these will play a pivotal
role in the endorsement of this vaccine by our future
physicians. In the short term these skills will also assist
students in discussing the importance of this vaccine
during their community engagement activities. Further
studies to evaluate the impact of these teaching strat-
egies aimed at millennial medical students are currently
being planned.
Limitations of the study
This study has several limitations. First, this study was
conducted at a single medical school on a relatively
small sample size that may limit generalizability. Al-
though national survey data may have revealed regional
variations, there are no indications that this institution’s
students are noticeably different from those in other US
allopathic medical schools. Self-reported data made it
difficult to verify the accuracy of respondents’ vaccin-
ation status and we did not assess age at initiation of the
vaccine. Also, this study did not seek to compare med-
ical student attitudes between HPV and other vaccines.
The survey was not designed to assess where the
students obtained their knowledge and how it may have
impacted their beliefs. Finally, the survey may have been
influenced by a response bias – between those who
responded to the email survey and those who opted not
to participate, which prevented us from identifying pos-
sible patterns of characteristics among non-respondents.
Conclusions
Medical students are a key audience for HPV-related com-
munication and training not only because of their




Benefits of vaccination 65 (57.5) “From a public health stand point I feel everyone in the susceptible age range should get
the HPV series because it really doesn’t harm anything, but it can be an effective way to
prevent the spread of a preventable disease. It is harder to change society behavior than to
arm people against the disease.”
Emphasis on offering vaccine to boys
and girls
17 (15.0) “promoting vaccination of males is essential. Many people, even fellow medical students,
were unaware that males could and should receive the vaccination. I believe its so important
because there is no test for men to get to know if they have HPV, and could unknowingly
pass it on to many partners without ever finding out.”
“Benefits outweigh the risks and it’s important for males to be vaccinated as well given the
risk of infecting their partners.”
Moral implications associated with the
HPV vaccine
15 (13.3) “Though I would recommend my patients to receive the vaccine, I do not think it would be
ethically wise to force it upon them”
“… vaccine is geared to protection of HPV as it is acquired sexually, therefore imposing this
would assume that the patient is or will be sexually active in the near future. This may
interfere with their personal and spiritual beliefs and thus making such assumptions would
be inappropriate….”
“I really think HPV and all vaccinations should be strongly encouraged but I am on the fence
about mandating them. I think mandates make people hostile and more likely to resist and
feel forced into decisions that they aren’t comfortable with. From a public health perspective
I think getting folks on board with HPV vaccination is a big deal, especially since now we are
seeing other cancers (not just cervical) related to it..”.
Need for counseling skills 8 (7.1) “I think we need to educate providers about the best ways to provide the information to
not make it sound like an STD vaccine.”
“When I got it Gardasil had just come out and then I moved so I never got the third one;
I wish my doctor had counseled me further (I don’t remember being counseled, just told by
her to get it)”
Need for education 10 (8.8) “To be honest, I never knew much about HPV vaccinations or the recommendations for it,
just that it existed.”
“Do not know enough about it to really have a view!”
a51% of reflections contained multiple themes (range 2–3)
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impending role as healthcare providers, but also as future
policy makers. We believe a particularly important contri-
bution made by this study is the perspective of millennial
medical students as a unique group of future healthcare
providers, who will be the first to have had a personal
experience with the vaccine. This study also highlights a
pervasive lack of understanding regarding the protection
against cancer other than cervical, conferred by the HPV
vaccine. Although students acknowledge the importance
of the vaccine and the need for patient education and
counseling to prevent HPV-related cancers through
vaccine compliance, they nonetheless feel ill prepared to
provide that counseling. Students should be taught age-
relevant approaches to counseling parents, adolescents,
and young adults about this cancer-preventing vaccine
that could save the lives of millions.
It is hoped that medical student personal experi-
ences with the vaccine, supplemented by medical
school education about HPV and appropriate vaccine-
counseling skills, will allow them to share information
with patients and parents in a clear, reassuring way,
devoid of stigma. We anticipate they will be health-
care providers who play a critical role in recommend-
ing the HPV vaccine and help protect young people
from life threatening cancers.
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